Cas:84-65-1 Anthraquinone manufacturer & supplier

We serve Chemical Name:Anthraquinone CAS:84-65-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Anthraquinone

Chemical Name:Anthraquinone
CAS.NO:84-65-1
Synonyms:anthraquinone;EINECS 201-549-0;9,10-anthracenedione;anthracene-9,10-dione;MFCD00001188
Molecular Formula:C14H8O2
Molecular Weight:208.212
HS Code:2914610000

Physical and Chemical Properties:
Melting point:284-286 °C(lit.)
Boiling point:377.0±12.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.659
PSA:34.14000
Exact Mass:208.052429
LogP:3.38

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like anthraquinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00001188 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 201-549-0 Use and application,MFCD00001188 technical grade,usp/ep/jp grade.


Related News: Our quality control staff then conducts analyses in the testing laboratory to examine whether the API manufactured is ultrapure. Anthraquinone manufacturer Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. Anthraquinone supplier Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. Anthraquinone vendor Our quality control staff then conducts analyses in the testing laboratory to examine whether the API manufactured is ultrapure. Anthraquinone factory Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.